HighVista Strategies »

Fabrinet shares owned by HighVista Strategies

Quarter-by-quarter ownership of Fabrinet (FN) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Fabrinet

Tip: Access up to 7 years of quarterly data

All positions including Fabrinet held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fabrinet by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 5.1k 364.62

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Fabrinet

BlackRock
Vanguard Group
FMR
Daniel D. Thurber
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Point72 Asset Management
Whale Rock Capital Management
Invesco
Citadel Advisors
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
Baillie Gifford & Co
Paradigm Capital Management

View all funds holding Fabrinet